Remo Kranich

This inventor holds 7 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignee: Revotar Biopharmaceuticals Ag. Active years: 2010-2013.

USPTO Granted Patents = 7 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 24(Granted Patents)

Company Filing History:

7 out of 7

Revotar Biopharmaceuticals Ag

patents

Years Active: 2010-2013

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8461207 - Phloroglucinol derivatives having selectin ligand activity (2013-06-11),

2. 8394835 - Aromatic compounds and their use in medical applications (2013-03-12),

3. 8367677 - Non-glycosylated/non-glycosidic/non-peptidic small molecule PSGL-1 mimetics for the treatment of inflammatory disorders (2013-02-05),

4. 8039601 - Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane (2011-10-18),

5. 7923473 - Aromatic compounds and their use in medical applications (2011-04-12),

6. 7919532 - Hydroxylated aromatic compounds (2011-04-05),

7. 7851501 - Aromatic nitrocatechol compounds and their use for modulating processes mediated by cell adhesion molecules (2010-12-14),

Title: Remo Kranich: Innovator in Pharmaceutical Compositions

Introduction

Remo Kranich is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate binding processes in medical applications. With a total of 7 patents to his name, Kranich's work is influential in advancing medical science.

Latest Patents

Kranich's latest patents include innovative pharmaceutical compositions. One of his notable inventions is related to phloroglucinol derivatives that exhibit selectin ligand activity. This invention includes pharmaceutical compositions comprising at least one compound of a specific formula and a pharmaceutically acceptable carrier. These compounds are useful in medicine, particularly in modulating in-vitro and in-vivo binding processes mediated by E-, P-, or selectin binding. Another significant patent involves aromatic compounds and their applications in medical settings. This patent also includes pharmaceutical compositions that can modulate similar binding processes, showcasing Kranich's focus on enhancing therapeutic efficacy.

Career Highlights

Remo Kranich is associated with Revotar Biopharmaceuticals AG, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing compounds that have practical applications in medicine. Kranich's contributions are vital in addressing various medical challenges through innovative solutions.

Collaborations

Kranich collaborates with esteemed colleagues such as Ewald Aydt and Anke Busemann. These partnerships enhance the research and development efforts at Revotar Biopharmaceuticals AG, fostering an environment of innovation and discovery.

Conclusion

Remo Kranich is a prominent figure in the pharmaceutical industry, known for his innovative patents and contributions to medical science. His work continues to impact the field positively, paving the way for future advancements in pharmaceuticals.